Effectiveness of Intravenous and Subcutaneous Calcitriol inthe Treatment of Secondary Hyperparathyroidism

Publisher： Karger

E-ISSN： 2235-3186|80|1|119-120

ISSN： 1660-8151

Source： Nephron, Vol.80, Iss.1, 1998-09, pp. : 119-120

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Effect of Intravenous Calcitriol Administration on Secondary Hyperparathyroidism

By  

Nephron, Vol. 90, Iss. 4, 2002-04 ,pp. : 413-423

Karger

Access to resources Recommend Favorite

Treatment of Secondary Hyperparathyroidism: Results of a Phase 2 Trial Evaluating an Intravenous Peptide Agonist of the Calcium-Sensing Receptor

By  

American Journal of Nephrology, Vol. 42, Iss. 5, 2015-0 ,pp. : 379-388

Karger

Access to resources Recommend Favorite

Effects of Calcitriol on Type 5b Tartrate-Resistant Acid Phosphatase and Interleukin-6 in Secondary Hyperparathyroidism

By  

Blood Purification, Vol. 24, Iss. 5-6, 2006-12 ,pp. : 423-430

Karger

Access to resources Recommend Favorite

Use of 2MD, a Novel Oral Calcitriol Analog, in Hemodialysis Patients with Secondary Hyperparathyroidism

By  

American Journal of Nephrology, Vol. 43, Iss. 3, 2016-04 ,pp. : 213-220

Karger

Access to resources Recommend Favorite

Vitamin D Analogs for the Treatment of Secondary Hyperparathyroidism

By  

Blood Purification, Vol. 20, Iss. 1, 2002-01 ,pp. : 109-112

Karger

Access to resources Recommend Favorite